We do have COVID-19 IgG/IgM Immunoassay rapid tests to fight the pandemic

Your Cart is Empty

How SCHISTO-H lurks behind the scenes of global women's health

October 28, 2016

How SCHISTO-H lurks behind the scenes of global women's health

Malaria is the most destructive parasitic illness, by many accounts, but the second most is much less well-known.

Schistosomiasis [shis-tuh-soh-mahy-uh-sis] infects over 250 million people.

It is a common in areas with stagnant water where the where the parasitic flat-worms can enter even unbroken skin and take up residence in a host. The flat worms then produce thousands of eggs per day that can overwhelm the host’s organs. The disease itself is effectively treated with praziquantel but reinfection can occur quickly. This is a disease desperate for a vaccine.

Schistosomiasis is of interest to Maternova because it is particularly harmful to pregnant women and young children as these populations have less developed or compromised immune systems. Repeated infection with schistosomiasis causes anemia and stunted growth. For girls, a specific strain we nickname SCHISTO-H is a threat to the reproductive organs. Furthermore, the scarring and wear and tear caused by SCHISTO-H can also leave girls and women more vulnerable to HIV.

How do you treat schisto? The drug, praziquantel, has been the sole recommended treatment to combat Schistosomiasis and has been around for over 30 years. A concern though, is that this common, effective (and cheap) treatment has not determined to be safe in pregnancy or dosed appropriately for very young children who seem to be much more susceptible to the disease. The [Pediatric Praziquantel Consortium has received nearly $5M from the Japanese GHIT to research a more safe and effective formulation of praziquantel for children](http://www.prnewswire.com/news-releases/pediatric-praziquantel-consortium-awarded-usd49-million-grant-from-global-health-innovative-technology-fund-505453661.html)

A vaccine is in development that has been proven to be effective in mice and is showing promise in water buffalo. Since this disease is spread in stagnant water contaminated with infected feces, it is thought that human infection would be greatly decreased by vaccinating some of the livestock.

Schistosomiasis is in a grouping of the WHO (World Health Organization) classifies as Neglected Tropical Diseases. Much more research is needed in areas of treatment AND vaccine.

Coming soon, information on rapid testing, and more about some exciting Schistosomiasis research from two Rhode Island researchers.

Maternova offers HIV 1/2 rapid test, as well as Schistosomiasis test

Paula McGovern and Meg Wirth

Leave a comment

Comments will be approved before showing up.

Also in The Maternova blog

Maternal Mortality in sub-Saharan Africa: Why is it so stubbornly high?

June 10, 2021

South Sudan is followed by Chad and Sierra Leone, with  1,140 and 1,120 maternal deaths per 100,000 live births  respectively. The three countries are the only ones in Africa where maternal mortality rates are higher than a thousand deaths per 100,000 live births.
Read More
The State of The World's Midwifery
The State of The World's Midwifery

May 17, 2021

Read More
Helmet CPAP respiratory circuits provide intermediate COVID-19 treatment before ventilators
Helmet CPAP respiratory circuits provide intermediate COVID-19 treatment before ventilators

March 15, 2021

Intermediate solutions to increase positive airway pressure and increase oxygen are in demand in order to keep patients off ventilators and provide an alternative means of treatment when nasal cannula fail and a patient is hypoxemic or at risk of acute respiratory distress syndrome (ARDS).  To put this in a layperson's terms, the pressure exerted by this Helmet CPAP respiratory circuit can actually keep parts of the patients' lungs open, even with very little oxygen flow.
Read More
News & Updates

Sign up to get the latest on sales, new releases and more …

maternal and newborn health news